Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Future Medicinal Chemistry
|
November 22, 2011
Advances in HIV microbicide development
Joanna S Olsen, David Easterhoff, Stephen Dewhurst
Journal of the American Chemical Society
|
January 14, 2012
Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection
Christina C Capule, Caitlin Brown, Joanna S Olsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2008
Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing
Rachel E Sutherland, Joanna S Olsen, Andrew McKinstry, et al.
The Journal of Biological Chemistry
|
February 23, 2012
Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide
Joanna S Olsen, John T M DiMaio, Todd M Doran, et al.
Biochemical and Biophysical Research Communications
|
June 24, 2014
Dipeptidyl peptidase I controls survival from Klebsiella pneumoniae lung infection by processing surfactant protein D
Rachel E Sutherland, Sophia S Barry, Joanna S Olsen, et al.
The Journal of Biological Chemistry
|
September 14, 2010
Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection
Joanna S Olsen, Caitlin Brown, Christina C Capule, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen
David Easterhoff, Fernando Ontiveros, Lauren R Brooks, et al.
BMJ (Clinical Research Ed.)
|
November 30, 2022
Oxygen administration during surgery and postoperative organ injury: observational cohort study
David R McIlroy, Matthew S Shotwell, Marcos G Lopez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Future Medicinal Chemistry
|
November 22, 2011
Advances in HIV microbicide development
Joanna S Olsen, David Easterhoff, Stephen Dewhurst
Journal of the American Chemical Society
|
January 14, 2012
Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection
Christina C Capule, Caitlin Brown, Joanna S Olsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2008
Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing
Rachel E Sutherland, Joanna S Olsen, Andrew McKinstry, et al.
The Journal of Biological Chemistry
|
February 23, 2012
Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide
Joanna S Olsen, John T M DiMaio, Todd M Doran, et al.
Biochemical and Biophysical Research Communications
|
June 24, 2014
Dipeptidyl peptidase I controls survival from Klebsiella pneumoniae lung infection by processing surfactant protein D
Rachel E Sutherland, Sophia S Barry, Joanna S Olsen, et al.
The Journal of Biological Chemistry
|
September 14, 2010
Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection
Joanna S Olsen, Caitlin Brown, Christina C Capule, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen
David Easterhoff, Fernando Ontiveros, Lauren R Brooks, et al.
BMJ (Clinical Research Ed.)
|
November 30, 2022
Oxygen administration during surgery and postoperative organ injury: observational cohort study
David R McIlroy, Matthew S Shotwell, Marcos G Lopez, et al.
Page
of 1